Indian pharmaceutical giant Sun Pharma is recalling 3,263 bottle of its anti-epilepsy medication Levetiracetam in the country after learning that batches of the drug failed the dissolution specifications test, The Economic Times reported on February 23.
The recall, which began on January 21, covers affected bottles that contain 60 counts of 750 mg Levetiracetam tablets. The U.S. Food and Drug Administration (FDA) categorized the recall as a “Class-II recall,” which means the affected products may cause temporary or medically reversible health conditions.
Representatives of the company declined to comment about the issue.
Defective pharmaceutical products like this may not only be ineffective in treating medical conditions, they may also pose serious threat to individuals, especially those with a weakened body and immune system. To learn more about taking legal action after being hurt by a defectively-manufactured drug in Milwaukee, speak with a product liability lawyer at Habush Habush & Rottier S.C. ® by calling (414) 271-0900 today.